|  | L1cam expression |  | |
---|---|---|---|---|
Characteristics | Total no. | Low No. cases (%) | High No. cases (%) | P value |
Age | Â | Â | Â | 0.169 |
 < 60 | 97 | 57(67) | 40(56) |  |
 ≥ 60 | 59 | 28(33) | 31(44) |  |
Gender | Â | Â | Â | 0.342 |
 Male | 106 | 55(64) | 51(72) |  |
 Female | 50 | 30(36) | 20(28) |  |
Tumor size | Â | Â | Â | 0.001a |
 <5 cm | 101 | 65(76) | 36(51) |  |
 ≥5 cm | 55 | 20(24) | 35(49) |  |
Differentiation status | Â | Â | Â | 0.290 |
 Well | 9 | 7(8) | 2(3) |  |
 Moderate | 87 | 48(56) | 39(55) |  |
 Poor and others | 60 | 30(36) | 30(42) |  |
Lymph node invasion | Â | Â | Â | 0.007a |
 Absent | 69 | 46(54) | 23(32) |  |
 Present | 87 | 39(46) | 48(68) |  |
Venous invasion | Â | Â | Â | 0.077 |
 Absent | 91 | 55(65) | 36(51) |  |
 Present | 65 | 30(35) | 35(49) |  |
Peritoneal dissemination | Â | Â | Â | 0.019a |
 Absent | 123 | 73(86) | 50(70) |  |
 Present | 33 | 12(14) | 21(30) |  |
Liver metastasis | Â | Â | Â | 0.013a |
 Absent | 114 | 69(81) | 45(63) |  |
 Present | 42 | 16(19) | 26(37) |  |
TNMb stage | Â | Â | Â | 0.002a |
 I-II | 48 | 35(41) | 13(18) |  |
 III-IV | 108 | 50(59) | 58(82) |  |
Therapeutic strategy | Â | Â | Â | 0.489 |
 Surgery only | 86 | 49(58) | 37(52) |  |
 Surgery + Chemotherapy | 70 | 36(42) | 34(48) |  |
Survival status | Â | Â | Â | < 0.001a |
 Alive | 72 | 52(61) | 20(28) |  |
 Dead | 84 | 33(39) | 51(72) |  |